MedTrace Logo

Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer

NCT00003014 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2013-12-04

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether chemotherapy is more effective than radiation therapy for testicular cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of carboplatin with that of radiation therapy in treating patients who have stage I testicular cancer.

Conditions

  • Testicular Germ Cell Tumor

Interventions

DRUG

carboplatin

RADIATION

radiation therapy

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    collaborator NETWORK

  • Medical Research Council

    lead OTHER_GOV

Principal Investigators

  • Hans Von Der Maase, MD · Aarhus Universitetshospital - Aarhus Sygehus

  • R. T. Oliver, MD · St. Bartholomew's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
16 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-04-30
Completion
2005-07-31

Countries

  • Brazil
  • Canada
  • Finland
  • Netherlands
  • Norway
  • South Africa
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003014 on ClinicalTrials.gov